2020;323:1061 - 9. 7. Curigliano G, Banerjee S, Cervantes A , et al. Managing cancer patients during the COVID -19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020;31:1320 -35. 8. Whisenant JG, Trama A, Torri V, et al. TERAVOLT: Thoracic Cancers International COVID -19 Collaboration. Cancer Cell. 2020;37:742 -5. 9. Hanna TP, Evans GA, Booth CM. Cancer, COVID -19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17:268 -70. 10. Dingemans AC, Soo RA, Jazieh AR, et al. Treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic. J Thorac Oncol. 202 0;15:1119 -36. 11. Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the COVID -19 epidemic in the Netherlands. Lancet Oncol. 2020 Jun;21:750 -751. 12. Dinmohamed AG, Cellamare M, Visser O, et al. The impact of the temporary suspension of national cancer screening programmes due to the COVID -19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J Hematol Oncol. 2020;13:147. 13. Gosain R, Abdou Y, Singh A, et al. COVID -19 and cancer: a comprehensive review. Curr Oncol Rep. 2020;22:53. 14. Robilotti EV, Babady NE, Mead PA, et al. Determinants of COVID -19 disease severity in patients with cancer. Nat Med. 2020;26:1218 -23. Version number: 6.0, 27 December 2021 43 of 49 15. Onder G, Rezza G, Brusaferro S. Case -fatality rate and characteristics of patients dying in relation to C OVID -19 in Italy. JAMA .